Page 52 - Helicobacter pylori and Gastric Cancer: From Tumor microenvironment to Immunotherapy
P. 52

 38. Shiotani, A., et al., Evidence that loss of sonic hedgehog is an indicator of Helicobater pylori-induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol, 2005. 100(3): p. 581-7.
39. Suzuki, H., et al., Down-regulation of a morphogen (sonic hedgehog) gradient in the gastric epithelium of Helicobacter pylori-infected Mongolian gerbils. J Pathol, 2005. 206(2): p. 186-97.
40. El-Zaatari, M., et al., Gli1 deletion prevents Helicobacter-induced gastric metaplasia and expansion of myeloid cell subsets. PLoS One, 2013. 8(3): p. e58935.
41. Zavros, Y., et al., Reduced pepsin A processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformation. J Biol Chem, 2007. 282(46): p. 33265-74.
42. Takemura, S., et al., S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats. American Journal of Physiology - Gastrointestinal and Liver Physiology, 2017.
43. Sierra, R., et al., Association of serum pepsinogen with atrophic body gastritis in Costa Rica. Clin Exp Med, 2006. 6(2): p. 72-8.
44. Iijima, K., et al., Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol, 2005. 40(10): p. 938-44.
45. Sipponen, P., et al., Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol, 2002. 37(7): p. 785-91.
46. Nomura, A.M., et al., Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J Infect Dis, 2005. 191(12): p. 2075-81.
47. Kokkola, A., et al., Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. World J Gastroenterol, 2005. 11(7): p. 1032-6.
48. Shiotani, A., et al., Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer, 2005. 115(3): p. 463-9.
49. Li, P., et al., Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease. BMC Clin Pathol, 2013. 13(1): p. 22.
50. Roberts, N.B., Review article: human pepsins - their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther, 2006. 24 Suppl 2: p. 2-9.
51. Fujinaga, M., et al., Crystal structure of human pepsin and its complex with
pepstatin. Protein Sci, 1995. 4(5): p. 960-72.
                                Chapter 2
Chapter 2
46
50
















































































   50   51   52   53   54